GLYCOMIMETICS INC (GLYC) Share-based Payment Arrangement, Expense USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Glycomimetics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2024.
  • Glycomimetics Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $1.19 M, a 37% increase year-over-year.
  • Glycomimetics Inc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $3.85 M, a 5.46% increase year-over-year.
  • Glycomimetics Inc annual Share-based Payment Arrangement, Expense for 2023 was $3.52 M, a 8.64% decline from 2022.
  • Glycomimetics Inc annual Share-based Payment Arrangement, Expense for 2022 was $3.86 M, a 36.6% decline from 2021.
  • Glycomimetics Inc annual Share-based Payment Arrangement, Expense for 2021 was $6.09 M, a 11.8% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.85 M $1.19 M +$322 K +37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.52 M $908 K +$9.17 K +1.02% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $3.52 M $888 K -$26.1 K -2.86% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $3.54 M $858 K -$106 K -11% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $3.65 M $870 K -$210 K -19.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.86 M $899 K -$421 K -31.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $4.28 M $914 K -$677 K -42.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $4.96 M $964 K -$598 K -38.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $5.55 M $1.08 M -$534 K -33.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $6.09 M $1.32 M -$308 K -18.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-27
Q3 2021 $6.39 M $1.59 M -$99.5 K -5.89% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $6.49 M $1.56 M -$200 K -11.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $6.69 M $1.61 M -$208 K -11.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $6.9 M $1.63 M -$98.5 K -5.71% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-29
Q3 2020 $7 M $1.69 M +$103 K +6.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $6.9 M $1.76 M +$242 K +15.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $6.65 M $1.82 M +$440 K +31.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 $6.22 M $1.73 M +$576 K +50.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-03
Q3 2019 $5.64 M $1.59 M +$416 K +35.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $5.22 M $1.52 M +$369 K +32.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $4.85 M $1.38 M +$267 K +23.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $4.59 M $1.15 M +$185 K +19.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-02
Q3 2018 $4.4 M $1.17 M +$209 K +21.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $4.19 M $1.15 M +$159 K +16.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $4.03 M $1.12 M +$273 K +32.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $3.76 M $965 K +$238 K +32.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 $3.52 M $962 K +$223 K +30.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $3.3 M $991 K +$219 K +28.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $3.08 M $843 K +$115 K +15.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $2.96 M $726 K +$81.2 K +12.6% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-06
Q3 2016 $2.88 M $739 K +$106 K +16.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $2.78 M $772 K +$313 K +68.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $2.46 M $728 K +$140 K +23.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $2.32 M $645 K +$162 K +33.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $2.16 M $633 K +$191 K +43.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $1.97 M $458 K +$39.8 K +9.51% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $1.93 M $588 K +$295 K +101% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $1.64 M $483 K +$422 K +696% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $1.21 M $442 K +$294 K +200% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $919 K $418 K +$309 K +282% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $610 K $292 K +$184 K +171% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $426 K $60.6 K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $147 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $110 K Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $108 K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.